Key result
In patients with non-ST elevation acute coronary syndrome, percutaneous coronary intervention at 24-72 hours did not significantly reduce the primary composite outcome of cardiac death and recurrent myocardial infarction compared to intervention within 24 hours (HR 0.70).
Why the study?
Does the timing of percutaneous coronary intervention (PCI) affect outcomes in patients with non-ST-elevation acute coronary syndromes?
Observational (n=984)
Yes
Does the timing of percutaneous coronary intervention (PCI) affect outcomes in patients with non-ST-elevation acute coronary syndromes?
Hazard Ratio: 0.7 (95% CI 0.3–1.63)
p-value: p=0.41
In high-risk NSTE-ACS patients, performing PCI within 24-72 hours from symptom onset optimizes outcomes compared to delayed intervention beyond 72 hours.
No significant outcome difference with PCI at 24-72 versus <24 hours; leaves open optimal timing in NSTE-ACS and requires RCTs.
BACKGROUND: Several large trials have indicated that a routine invasive strategy was favored for high-risk patients with non-ST-elevation acute coronary syndromes. However, the optimal timing for this intervention is unclear. METHODS: We included patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI) from the Taiwan acute coronary syndrome registry. Thrombolysis in Myocardial Infarction (TIMI) score was used to stratify our patients into three groups: low (TIMI 0-2), intermediate (TIMI 3-4) and high risk (TIMI 5-7).We analyzed outcomes according to the timing of PCI. RESULTS: Overall, 984 patients were included in this study. For primary outcomes including cardiac death and recurrent myocardial infarction, early PCI within 24 hours did not show benefits over late PCI (24-72 or > 72 hours) (p > 0.05) in the low and intermediate risk groups. However, in the high risk group, patients who underwent PCI after 72 hours had significantly worse primary outcomes than those who underwent PCI within 24-72 hours. For secondary outcomes including non-cardiac death, unplanned revascularization, and major bleeding, the events rate was significantly higher for early or delayed PCI in low-risk patients when compared with patients who underwent PCI within 24-72 hours. CONCLUSIONS: In our study, for high-risk NSTE-ACS patients, PCI within 24-72 hours from symptom onset is demonstrably the optimum time for PCI. Delayed PCI over 72 hours is associated with the worst outcomes and should be avoided. For patients with low risks, routine early PCI < 24 hours after PCI is not beneficial.
No takes yet. Share an insight, caveat, or question.
Shyu et al. (2016) conducted an observational in Non-ST elevation acute coronary syndrome (NSTE-ACS) (n=984). Timing of percutaneous coronary intervention vs. Early (<24 hours) vs delayed (24-72 hours or >72 hours) intervention was evaluated on Composite of cardiac death and recurrent non-fatal myocardial infarction at 1 year (HR 0.70, 95% CI 0.30-1.63, p=0.41). In patients with non-ST elevation acute coronary syndrome, percutaneous coronary intervention at 24-72 hours did not significantly reduce the primary composite outcome of cardiac death and recurrent myocardial infarction compared to intervention within 24 hours (HR 0.70).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: